“Metastatic Hormone-Sensitive Prostate Cancer: The Role of Docetaxel in Triple-Therapy Regimens” (2025) Voprosy onkologii, 71(4), p. OF-2167. doi:10.37469/0507-3758-2025-71-4-OF-2167.